TY  - JOUR 
AU  - Janusz, Kamila
AU  - Izquierdo, Marta Martín
AU  - Cadenas, Félix López
AU  - Ramos, Fernando
AU  - Sánchez, Jesús María Hernández
AU  - Lumbreras, Eva
AU  - Robledo, Cristina
AU  - Del Real, Javier Sánchez
AU  - Caballero, Juan Carlos
AU  - Collado, Rosa
AU  - Bernal, Teresa
AU  - Pedro, Carme
AU  - Insunza, Andrés
AU  - de Paz, Raquel
AU  - Xicoy, Blanca
AU  - Salido, Eduardo
AU  - García, Joaquín Sánchez
AU  - Mínguez, Sandra Santos
AU  - García, Cristina Miguel
AU  - Muñoz, Ana María Simón
AU  - Sánchez Barba, Mercedes
AU  - Hernández Rivas, Jesús María
AU  - Abáigar ,María
AU  - Campelo, María Díez
PY  - 2021
UR  - http://hdl.handle.net/10366/171383
AB  - [EN]SF3B1 is a highly mutated gene in myelodysplastic syndrome (MDS) patients, related to a specific subtype and parameters of good prognosis in MDS without excess blasts. More than 40% of MDS patients carry at least two myeloid-related gene mutations...
LA  - eng
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - DNA (Cytosine-5-)-Methyltransferases
KW  - DNA Methyltransferase 3A
KW  - DNA Mutational Analysis
KW  - DNA-Binding Proteins
KW  - Dioxygenases
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Myelodysplastic Syndromes
KW  - Phosphoproteins
KW  - Prognosis
KW  - Proto-Oncogene Proteins
KW  - RNA Splicing Factors
KW  - Prognosis
KW  - Aged
KW  - DNA Mutational Analysis
KW  - Mutation
KW  - Adult
KW  - DNA-Binding Proteins
KW  - Humans
KW  - Proto-Oncogene Proteins
KW  - Myelodysplastic Syndromes
KW  - Dioxygenases
KW  - Middle Aged
KW  - Phosphoproteins
TI  - Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients
DO  - 10.1007/s00277-020-04360-4
T2  - Annals of hematology
VL  - 100
M2  - 1995
ER  -